6th Annual MarketsandMarkets

Real-World Evidence and Life Sciences Analytics Conference

16th - 17th October 2023

Boston, USA

To Pioneer the Integration of RWE/RWD into Experimental and Regulatory Approach

MarketsandMarkets is proud to announce the 6th Annual Real-World Evidence and Life Sciences Conference to be held on October 16th - 17th, 2023 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2023.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes. Telemedicine and virtual care may also provoke a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.

Additionally with the new guidance by the FDA around data quality and data standards, the stakeholders are seeking to learn its long term impact and safety surveillance. This conference will focus on above said significant points and hold discussions on the best practices adopted by various stakeholders with a key takeaway being better decision making.

WHAT TO EXPECT

  • Regulatory view around data quality & data standards.
  • Leveraging RWE for improving market access.
  • The adoption & role of AI & ML in clinical trials.
  • Real-world evidence & Digital Health - The expanded role of RWE for digital health.
  • Panel Discussion on lessons learned from the recent results of the FDA’s
    pilot program RCT DUPLICATE.
  • Real-World Data & Advanced Analytics.
  • RWE to inform decision making process in rare diseases where there is lack of evidence.

  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

Real-World Evidence, Real-World Data, Health Economics & Outcomes Research- HEOR, Market Access/Value Access, Clinical Outcomes, Clinical Development & research, Clinical trial and others

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

Keynote- Real World Data – To Drive Integrated Evidence Generation

09:00 - 09:30

Maximizing the influence of RWD in cases of Rare Diseases

09:30 - 10:00

Maximizing the influence of RWD in cases of Rare Diseases

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:20

Role of Data Quality in advancing the use of RWE for Regulatory Decision Making

11:20 - 11:50

Application of RWD/RWE in Strategy Framework and Regulatory Considerations

11:50 - 12:20

Solution Providers Presentation

12:20 - 12:50

Panel Discussion – Creating Value from Next Generation RWE

12:50 - 13:20

Lunch and Poster Presentation | One-to-One Networking

13:20 - 14:20

Research and Related Initiatives to Evaluate and Improve RWD for Evidence Generation

14:20 - 14:50

RWD in Drug Development Program

14:50 - 15:20

Solution Providers Presentation

15:20 - 15:50

Evening Refreshments and Poster Presentation | One-to-One Networking Meetings

15:50 - 16:30

Current Trends in Patient-Centric Clinical Research amid the Rapidly evolving Landscape

16:30 - 17:00

Patient Engagement Strategy and Execution

17:00 - 17:30

Achieving Patient Diversity using RWE in Clinical Trials

17:30 - 18:00

Closing remarks by the Chairperson

18:00 - 18:00

END OF DAY 1 | Drinks Reception and Networking

18:00 - 18:00

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks from the Chairman

08:55 - 09:00

RWE- Trends in Global Market and Network Access

09:00 - 09:30

Patient Access to Precision Medicine Oncology

09:30 - 10:00

Solution Provider Presentation

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Obtain Insight into HEOR Complexities, Parameters and Opportunities

11:15 - 11:45

Solution Providers Presentation

11:45 - 12:15

Global Landscape around Real- World Evidence

12:15 - 12:45

Panel Discussion - Patient Engagement Strategy and Execution

12:45 - 14:15

Pricing Market Access Strategies Case Studies

14:15 - 14:45

Assessing Patient centered approach to value-based approach

14:45 - 15:15

Closing remarks by the chairperson

15:15 - 15:15

End of Conference

15:15 - 15:15

ENQUIRE NOW

SPONSORS

Magnolia Innovation
Adelphi Real World
HealthVerity

LOCATION

Venue

Boston, USA

PAST EVENT GALLERY